Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB
Mandate

Vinge advises Eleda in connection with the acquisition of Göteborg Mark och Betong Entreprenad AB

January 13, 2021 Employment and Benefits Corporate Crime & Compliance Real Estate and Construction M&A General Corporate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Göteborg Mark och Betong Entreprenad AB (“GMB”).

GMB is based in Gothenburg and provides construction and contracting services related to infrastructure, foundation and fine planning work as well as both cast-in-place and prefabricated concrete. GMB has a total approximate revenue of SEK 220 million and around 30 employees.

Vinge’s team consisted primarily of partner Christina Kokko and associates Michaela Cronemyr and Carl Fredrik Wachtmeister (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Frida Ställborn (Real Property & Environment), Tove Lövgren Frisk (Compliance) and Carl Bruneheim (VDR-specialist).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025